Zhejiang University
Clinical trials sponsored by Zhejiang University, explained in plain language.
-
Experimental cell infusion targets tough liver tumors
Disease control OngoingThis early-stage study tests a new cell therapy called CT0180 in 21 adults with advanced liver cancer that has not responded to other treatments. The main goals are to check safety, find the best dose, and see how long the cells stay in the body. Participants receive one or more …
Phase: PHASE1 • Sponsor: Zhejiang University • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
Supercharged immune cells take on Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests a new cell therapy (NW-301VT) for people with advanced solid tumors that have a specific KRAS mutation and a particular immune type (HLA-A*11:01). The treatment involves taking a patient's own T cells, genetically engineering them to recognize and att…
Phase: PHASE1 • Sponsor: Zhejiang University • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
AI-Powered CT scans could revolutionize early liver cancer detection
Diagnosis OngoingThis study uses CT scans and artificial intelligence (AI) to improve early detection of liver cancer. Researchers will analyze images from 10,000 patients with confirmed liver tumors to train an AI model to spot and outline tumors more accurately. The goal is to create a better s…
Phase: NA • Sponsor: Zhejiang University • Aim: Diagnosis
Last updated Apr 30, 2026 15:52 UTC